💠 Buying NVO & IPAR

While the intention of CyberMoat is to focus on cybersecurity investments, this one goes out of scope — but for a reason.

📈 From a broader investment perspective, when the S&P 500 keeps hitting new highs — and these highs are almost entirely driven by tech companies (with the AI bubble still inflating) — the situation becomes clear: tech valuations are stretched.

💸 Many companies trade at P/E multiples of 30–40×, and the trendiest ones even in the hundreds. That means risk — sometimes extreme.

Naturally, that makes me look elsewhere — at sectors that might offer better safety and stronger long-term potential, precisely because they could be deeply undervalued right now.

So, for the record — let’s see in a few quarters or years whether this reasoning holds up.

🧩 I’ve built a position in Novo Nordisk (CPH:NOVO.B) @ avg. price 322.5 DKK, forward P/E ≈ 12.9.
🧩 Another position in Inter Parfums (NASDAQ: IPAR) @ avg. price 89.21 USD, forward P/E ≈ 17.2.

Maybe I’m a bit early — but it’s nearly impossible to time the market.
And no, I don’t have a crystal ball either 🔮

⚠️ This is not investment advice. I’m sharing this as a learning note — my qualifications are next to none.